Same Drug, 2,200 Different Prices
Middlemen negotiate widely different prices for prescriptions, depending on your Medicare insurance plan.
Related Articles
Genitourinary Cancer Expert Yüksel Ürün, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance
In this installment of The ASCO Post’s Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with medical oncologist Yüksel Ürün, MD,…
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
Nature Reviews Clinical Oncology – Third-generation EGFR tyrosine-kinase inhibitors (TKIs) are the standard-of-care first-line treatment for patients with advanced-stage EGFR-mutant NSCLC and their…
Semaglutide Rocketing Past Statins as Millions Eligible
A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.
66th ASH Annual Meeting: Chasing Zebras: Navigating Rare Myeloid Neoplasms
Description: It turns out the old adage from our medical school days, “If you hear hoofbeats, think of horses, not zebras,” was not completely correct!…
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial
This large, randomised, placebo-controlled, double-blind, clinical trial showed no effect of the traditional Chinese medicine herbal compound FYTF-919 on functional recovery, survival, and health-related quality…
HLH: diagnostics revisited and improved
In this issue of Blood, Henter et al report on the updated hemophagocytic lymphohistiocytosis (HLH)-2004 diagnostic criteria for primary or familial hemoph
A new moonshot initiative to fight cervical cancer in the Indo-Pacific region is missing something
The Quad Cancer Moonshot Initiative to fight cervical cancer in the Indo-Pacific region is admirable, but three of the four partners aren’t practicing what they…
Early T2D Diagnosis Heightens Risks for Complications, Death
Those diagnosed with type 2 diabetes when younger than 40 years of age had greater risks for several diabetes-related outcomes.
Welcome to Own Your Labs – Own Your Labs
Click Here to Get Started Hello everyone – welcome to Own Your Labs We’ve long been getting our blood testing a bit cheaper than most through…
Drugs prescribed off-label may do more harm than good
A new study from King’s College London shows that off-label prescriptions of a common antidepressant doesn’t help breathlessness in patients with respiratory disease – and…